| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A synthesized peptide derived from human TCEA1 was used as the immunogen for the TCEA1 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
TCEA1 Antibody / Transcription elongation factor A protein 1 is a anti-TCEA1 Rabbit antibody Recombinant Rabbit Monoclonal clone 29T88 supplied in Liquid format. Recommended for workflows such as Western blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunoprecipitation (IP) with listed reactivity in Human, Mouse, Rat. Reported localization: Nuclear, cytoplasmic.
Key elements and design rationale
- Target: TCEA1
- Antibody details: Rabbit, Recombinant Rabbit Monoclonal, clone 29T88, isotype Rabbit IgG
- Format: Liquid
- Applications (as listed): WB, IHC, ICC, IF, IP
Biological background
Transcription elongation factor A protein 1 enhances the activity of RNA polymerase II by stimulating transcript elongation and resolving transcriptional arrest. Research using TCEA1 antibody has shown that it acts as a transcriptional cofactor by interacting with paused polymerase complexes and promoting the resumption of RNA synthesis. This activity ensures efficient transcription of protein coding genes, supporting diverse cellular processes including growth, proliferation, and differentiation.
Studies with TCEA1 antibody have revealed that this factor also contributes to transcription coupled DNA repair. When RNA polymerase II encounters DNA damage, TCEA1 facilitates backtracking of the polymerase, enabling access for repair enzymes. This role links transcriptional regulation with genome stability and provides a mechanism for protecting cells from genotoxic stress. Dysregulation of this pathway may impair DNA repair capacity and promote disease development.
Beyond transcriptional elongation, Transcription elongation factor A protein 1 influences chromatin remodeling. Research using TCEA1 antibody has demonstrated that it cooperates with other transcriptional cofactors to modify chromatin architecture, enhancing promoter clearance and elongation efficiency. This highlights its integration into a broader regulatory network that coordinates transcription with chromatin state.
Dysregulation of TCEA1 expression has been implicated in cancer and neurological disease. Studies with TCEA1 antibody have shown that altered levels can disrupt transcription fidelity, impair DNA repair, and promote genomic instability. Overexpression in some cancers may provide tumor cells with enhanced transcriptional capacity, while deficiencies have been linked to neurodegeneration. These findings underscore its importance in both health and pathology.
TCEA1 antibody is commonly applied in western blotting, immunohistochemistry, and chromatin immunoprecipitation. Western blotting detects protein expression levels, immunohistochemistry reveals nuclear localization in tissue, and chromatin immunoprecipitation maps binding to actively transcribed genes. These applications make TCEA1 antibody indispensable for transcription biology research.
By supplying validated TCEA1 antibody reagents,
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Immunofluorescence: visualize subcellular distribution and cell-to-cell heterogeneity.
- Immunohistochemistry: map target signal in tissue context and compare regions/phenotypes.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Monoclonal antibodies provide a defined epitope recognition profile that can support consistent comparisons across experiments.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
